Location History:
- Prato, IT (2016)
- Florence, IT (2018)
Company Filing History:
2 out of 29 
2 out of 669 
Years Active: 2016-2018
Title: Costanza Bogani: Innovator in Cancer Therapy
Introduction
Costanza Bogani is a prominent inventor based in Florence, Italy. She has made significant contributions to the field of cancer therapy, particularly through her innovative combination therapies. With a total of two patents to her name, she is recognized for her work in developing treatments that target various cancers.
Latest Patents
Costanza's latest patents include a combination therapy that utilizes an mTOR inhibitor and a JAK inhibitor. This therapy is designed to treat a variety of cancers, including myeloproliferative neoplasms, and is also effective for treating JAK-associated diseases. Additionally, she has developed a JAK PI3K/mTOR combination therapy, which comprises a JAK kinase inhibitor and a dual PI3K/mTOR inhibitor. This therapy aims to provide methods for treating various cancers through its innovative approach.
Career Highlights
Throughout her career, Costanza has worked with notable companies in the pharmaceutical industry, including Novartis Pharma AG and Incyte Corporation. Her experience in these organizations has allowed her to refine her expertise in cancer research and therapy development.
Collaborations
Costanza has collaborated with esteemed colleagues such as Alessandro M. Vannucchi and Niccolo Bartalucci. These partnerships have further enhanced her research and contributed to her success in the field.
Conclusion
Costanza Bogani is a trailblazer in the development of innovative cancer therapies. Her work continues to impact the medical community and offers hope for improved treatment options for patients.